| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ADP binding | 3.67e-05 | 48 | 157 | 5 | GO:0043531 | |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 6.14e-05 | 2 | 157 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 6.14e-05 | 2 | 157 | 2 | GO:0004342 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor | 6.14e-05 | 2 | 157 | 2 | GO:0046857 | |
| GeneOntologyMolecularFunction | GMP reductase activity | 6.14e-05 | 2 | 157 | 2 | GO:0003920 | |
| GeneOntologyBiologicalProcess | platelet activating factor biosynthetic process | 4.04e-06 | 5 | 154 | 3 | GO:0006663 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 4.04e-06 | 5 | 154 | 3 | GO:0045053 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | GALC GNPDA1 ASRGL1 AUH MAT1A VPS13C GPX1 WNK1 PGAM5 PM20D2 GGT5 DUOX1 VPS13D OXCT1 PLA2G4C WDR6 ALDH1L2 GNPDA2 GLS VPS13A PLA2G4A ATP6V0D2 SMPD3 RMC1 SORD | 6.31e-06 | 1253 | 154 | 25 | GO:0044248 |
| GeneOntologyBiologicalProcess | small molecule catabolic process | GNPDA1 ASRGL1 AUH MAT1A PGK1 PM20D2 ADH7 GK2 OXCT1 ALDH1L2 GNPDA2 GLS SORD | 1.72e-05 | 421 | 154 | 13 | GO:0044282 |
| GeneOntologyBiologicalProcess | platelet activating factor metabolic process | 3.32e-05 | 9 | 154 | 3 | GO:0046469 | |
| GeneOntologyBiologicalProcess | glucosamine catabolic process | 5.54e-05 | 2 | 154 | 2 | GO:0006043 | |
| GeneOntologyBiologicalProcess | ether lipid biosynthetic process | 1.10e-04 | 13 | 154 | 3 | GO:0008611 | |
| GeneOntologyBiologicalProcess | glycerol ether biosynthetic process | 1.10e-04 | 13 | 154 | 3 | GO:0046504 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine acyl-chain remodeling | 1.40e-04 | 14 | 154 | 3 | GO:0036151 | |
| GeneOntologyBiologicalProcess | ether biosynthetic process | 1.40e-04 | 14 | 154 | 3 | GO:1901503 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 1.40e-04 | 14 | 154 | 3 | GO:0010572 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 1.63e-04 | 37 | 154 | 4 | GO:0042219 | |
| GeneOntologyBiologicalProcess | fructose biosynthetic process | 1.65e-04 | 3 | 154 | 2 | GO:0046370 | |
| GeneOntologyBiologicalProcess | N-acetylglucosamine catabolic process | 1.65e-04 | 3 | 154 | 2 | GO:0006046 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 2.12e-04 | 272 | 154 | 9 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 2.12e-04 | 272 | 154 | 9 | GO:0046395 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar metabolic process | 3.22e-04 | 44 | 154 | 4 | GO:0009225 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 3.29e-04 | 4 | 154 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | S-adenosylmethionine biosynthetic process | 3.29e-04 | 4 | 154 | 2 | GO:0006556 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | ADCY4 HMGCS1 GMPR2 MDH2 ME1 PGK1 GK2 PLA2G4C LPCAT2 SLC25A1 PLA2G4A GMPR ATP5F1A SORD | 3.44e-04 | 644 | 154 | 14 | GO:0090407 |
| GeneOntologyCellularComponent | GMP reductase complex | 5.68e-05 | 2 | 158 | 2 | GO:1902560 | |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 1.69e-04 | 3 | 158 | 2 | GO:0048269 | |
| Domain | VPS13 | 5.50e-07 | 3 | 154 | 3 | IPR026847 | |
| Domain | VPS13_mid_rpt | 5.50e-07 | 3 | 154 | 3 | PF16910 | |
| Domain | VPS13 | 5.50e-07 | 3 | 154 | 3 | PF16908 | |
| Domain | VPS13_N2 | 5.50e-07 | 3 | 154 | 3 | IPR031646 | |
| Domain | VPS13_mid_rpt | 5.50e-07 | 3 | 154 | 3 | IPR031642 | |
| Domain | Filamin | 1.40e-06 | 11 | 154 | 4 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.40e-06 | 11 | 154 | 4 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.40e-06 | 11 | 154 | 4 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.40e-06 | 11 | 154 | 4 | IPR017868 | |
| Domain | SHR-BD | 2.19e-06 | 4 | 154 | 3 | IPR009543 | |
| Domain | VPS13_C | 2.19e-06 | 4 | 154 | 3 | PF16909 | |
| Domain | VPS13_C | 2.19e-06 | 4 | 154 | 3 | IPR031645 | |
| Domain | SHR-BD | 2.19e-06 | 4 | 154 | 3 | PF06650 | |
| Domain | Ig_E-set | 2.46e-05 | 104 | 154 | 7 | IPR014756 | |
| Domain | Chorein_N | 2.99e-05 | 8 | 154 | 3 | PF12624 | |
| Domain | VPS13_N | 2.99e-05 | 8 | 154 | 3 | IPR026854 | |
| Domain | IG_FLMN | 6.32e-05 | 10 | 154 | 3 | SM00557 | |
| Domain | S-AdoMet_synt_N | 6.75e-05 | 2 | 154 | 2 | PF00438 | |
| Domain | Glucosamine6P_isomerase_CS | 6.75e-05 | 2 | 154 | 2 | IPR018321 | |
| Domain | Glucosamine6P_isomerase | 6.75e-05 | 2 | 154 | 2 | IPR004547 | |
| Domain | S-AdoMet_synthetase | 6.75e-05 | 2 | 154 | 2 | IPR002133 | |
| Domain | GLC_GALNAC_ISOMERASE | 6.75e-05 | 2 | 154 | 2 | PS01161 | |
| Domain | S-AdoMet_synt_M | 6.75e-05 | 2 | 154 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 6.75e-05 | 2 | 154 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 6.75e-05 | 2 | 154 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 6.75e-05 | 2 | 154 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 6.75e-05 | 2 | 154 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 6.75e-05 | 2 | 154 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 6.75e-05 | 2 | 154 | 2 | IPR022628 | |
| Domain | GMPR | 6.75e-05 | 2 | 154 | 2 | IPR005993 | |
| Domain | ADOMET_SYNTHASE_1 | 6.75e-05 | 2 | 154 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 6.75e-05 | 2 | 154 | 2 | PS00377 | |
| Domain | IMPDH | 4.01e-04 | 4 | 154 | 2 | PF00478 | |
| Domain | IMP_DH_GMPRt | 4.01e-04 | 4 | 154 | 2 | IPR001093 | |
| Domain | IMP_DH_GMP_RED | 4.01e-04 | 4 | 154 | 2 | PS00487 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 4.01e-04 | 4 | 154 | 2 | IPR015875 | |
| Domain | Glc/Gal-6P_isomerase | 4.01e-04 | 4 | 154 | 2 | IPR006148 | |
| Domain | Glucosamine_iso | 4.01e-04 | 4 | 154 | 2 | PF01182 | |
| Domain | - | 5.11e-04 | 169 | 154 | 7 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 5.87e-04 | 173 | 154 | 7 | IPR016040 | |
| Domain | Autophagy-rel_C | 6.65e-04 | 5 | 154 | 2 | IPR015412 | |
| Domain | ATG_C | 6.65e-04 | 5 | 154 | 2 | PF09333 | |
| Domain | Ig-like_fold | FLNA FLNB COL6A3 FLNC MYCBP2 SPEG NRG2 VSIG10 PLXNB2 HAVCR1 TGM1 IGHD SLAMF7 PLXNB1 ADGRA3 | 7.51e-04 | 706 | 154 | 15 | IPR013783 |
| Domain | ACTININ_2 | 8.63e-04 | 23 | 154 | 3 | PS00020 | |
| Domain | ACTININ_1 | 8.63e-04 | 23 | 154 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.63e-04 | 23 | 154 | 3 | IPR001589 | |
| Domain | - | FLNA FLNB COL6A3 FLNC MYCBP2 SPEG NRG2 VSIG10 PLXNB2 HAVCR1 TGM1 SLAMF7 PLXNB1 ADGRA3 | 1.20e-03 | 663 | 154 | 14 | 2.60.40.10 |
| Domain | AAA | 1.25e-03 | 144 | 154 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.25e-03 | 144 | 154 | 6 | IPR003593 | |
| Domain | PLA2_B | 1.38e-03 | 7 | 154 | 2 | PF01735 | |
| Domain | PLA2C | 1.38e-03 | 7 | 154 | 2 | PS51210 | |
| Domain | LysoPLipase_cat_dom | 1.38e-03 | 7 | 154 | 2 | IPR002642 | |
| Domain | PLAc | 1.38e-03 | 7 | 154 | 2 | SM00022 | |
| Domain | ADH_Zn_CS | 1.83e-03 | 8 | 154 | 2 | IPR002328 | |
| Domain | ADH_ZINC | 1.83e-03 | 8 | 154 | 2 | PS00059 | |
| Domain | Helicase/UvrB_N | 1.83e-03 | 8 | 154 | 2 | IPR006935 | |
| Domain | ResIII | 1.83e-03 | 8 | 154 | 2 | PF04851 | |
| Domain | CH | 2.04e-03 | 65 | 154 | 4 | SM00033 | |
| Domain | Plexin_cytopl | 2.34e-03 | 9 | 154 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.34e-03 | 9 | 154 | 2 | IPR013548 | |
| Domain | Plexin | 2.34e-03 | 9 | 154 | 2 | IPR031148 | |
| Domain | Ntn_hydrolases_N | 2.50e-03 | 33 | 154 | 3 | IPR029055 | |
| Domain | CH | 2.67e-03 | 70 | 154 | 4 | PF00307 | |
| Domain | - | 2.81e-03 | 71 | 154 | 4 | 1.10.418.10 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNA FLNB FLNC GNPDA1 RPLP2 MAP4 MAT2A PSMA2 GPX1 CAST UBA3 GMPR2 ECPAS WNK1 ME1 RUVBL2 RCC2 AARSD1 USP19 OXCT1 SBNO1 AHNAK GNPDA2 GLS PLA2G4A SDF2L1 IRF2BPL EIF3J GMPPA FUBP3 SORD | 7.12e-13 | 1455 | 159 | 31 | 22863883 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA FLNB FLNC RPLP2 MYCBP2 MAP4 CDK12 MAT2A PSMA2 CAST HMGCS1 MDH2 ECPAS ME1 RUVBL2 PGK1 BANF1 RCC2 PCYOX1L MDN1 FAM120A AHNAK SDF2L1 EIF3J RPL5 ATP5F1A | 1.75e-11 | 1149 | 159 | 26 | 35446349 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA FLNB FLNC ERCC3 RPLP2 MYCBP2 MAP4 MAT2A PSMA2 RUVBL2 PGAM5 SLC1A5 PGK1 AARSD1 TGM1 OXCT1 MDN1 FAM120A WDR6 SLC25A1 AHNAK GLS YME1L1 FUBP3 RPL5 ATP5F1A SORD | 1.15e-10 | 1353 | 159 | 27 | 29467282 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNA FLNB FLNC MLEC MYCBP2 PSMA2 PCDHA8 MUC5B MDH2 ECPAS ME1 RUVBL2 SLC1A5 PGK1 DUOX1 MDN1 SLC25A1 AHNAK RPL5 ATP5F1A SORD | 1.52e-10 | 807 | 159 | 21 | 30575818 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA FLNB ADCY4 MLEC RPLP2 MAP4 VPS13C MAT2A MDH2 ECPAS RUVBL2 PGAM5 SLC1A5 PGK1 RCC2 USP19 MDN1 FAM120A SBNO1 WDR6 GLS MYO18B FUBP3 RPL5 ATP5F1A ADGRA3 CDK4 | 3.59e-10 | 1425 | 159 | 27 | 30948266 |
| Pubmed | FLNA FLNB FLNC MAP4 PPFIA4 CAST AIRE PCDHA8 PCDHA6 RRAS TGDS VPS13A MYO18B FUBP3 | 4.27e-10 | 329 | 159 | 14 | 17474147 | |
| Pubmed | FLNA FLNB FLNC RPLP2 MAP4 PSMA2 ITGA5 MDH2 ECPAS RUVBL2 PGAM5 PGK1 RCC2 MDN1 SLC25A1 AHNAK FUBP3 RPL5 ATP5F1A | 7.13e-10 | 707 | 159 | 19 | 19738201 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNA FLNB FLNC MAP4 MAT2A SQLE MUC5B HMGCS1 MDH2 ECPAS WNK1 PLXNB2 RUVBL2 PGK1 RCC2 AARSD1 USP19 TGM1 OXCT1 SLC25A1 AHNAK IRF2BPL EIF3J FUBP3 RPL5 ATP5F1A | 7.33e-10 | 1367 | 159 | 26 | 32687490 |
| Pubmed | FLNA FLNB FLNC RPLP2 MYCBP2 MAP4 ECPAS PGAM5 PGK1 RCC2 MDN1 FAM120A WDR6 AHNAK FUBP3 RPL5 | 6.08e-08 | 653 | 159 | 16 | 22586326 | |
| Pubmed | FLNA ERCC3 RPLP2 MAP4 MAT2A PSMA2 GPX1 HMGCS1 MDH2 ME1 RUVBL2 AHDC1 PGAM5 PGK1 RCC2 TNRC18 FAM120A SLC25A1 EIF3J GMPPA RPL5 ATP5F1A | 6.41e-08 | 1247 | 159 | 22 | 27684187 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNA FLNB FLNC MAT2A HMGCS1 ITGA5 MDH2 WNK1 PGK1 MDN1 FAM120A SDF2L1 | 7.03e-08 | 344 | 159 | 12 | 30333137 |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 12393796 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 11153914 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 11252955 | ||
| Pubmed | FLNA FLNB MLEC CDK12 MAT2A HMGCS1 MDH2 ECPAS RUVBL2 PGAM5 SLC1A5 USP19 SLC25A1 GLS GMPPA ATP5F1A CDK4 SORD | 1.27e-07 | 878 | 159 | 18 | 37223481 | |
| Pubmed | FLNA FLNB FLNC PPFIA4 PSMA2 EML6 SHB RBM42 ABCC5 MDH2 PGAM5 PGK1 BANF1 TNRC18 MDN1 SBNO1 SLC25A1 AHNAK GLS VPS13A FUBP3 ATP5F1A RBBP9 | 1.89e-07 | 1442 | 159 | 23 | 35575683 | |
| Pubmed | FLNA FLNC RPLP2 MAP4 MAT2A RUVBL2 SLC1A5 MDN1 WDR6 ALDH1L2 SLC25A1 SDF2L1 GMPPA RPL5 ATP5F1A CDK4 | 2.49e-07 | 725 | 159 | 16 | 27025967 | |
| Pubmed | 2.91e-07 | 13 | 159 | 4 | 37179372 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | FLNA FLNB FLNC MAP4 CDK12 VPS13C PSMA2 RUVBL2 PGK1 VPS13D OXCT1 LPCAT2 OSR1 ATP5F1A | 3.63e-07 | 564 | 159 | 14 | 21565611 |
| Pubmed | FLNA FLNB FLNC MLEC RPLP2 MAT2A SLC1A5 PGK1 RCC2 TGM1 SLC25A1 AHNAK GLS SDF2L1 FUBP3 RPL5 ATP5F1A | 3.70e-07 | 844 | 159 | 17 | 25963833 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 3.74e-07 | 4 | 159 | 3 | 22802962 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 15498460 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | FLNA FLNB RPLP2 MAP4 RRAS PGAM5 PGK1 BANF1 RCC2 FAM120A SLC25A1 AHNAK RPL5 ATP5F1A | 5.06e-07 | 580 | 159 | 14 | 35676659 |
| Pubmed | RPLP2 MAP4 ECPAS RUVBL2 PGAM5 PGK1 RCC2 TGM1 SLC25A1 AHNAK FUBP3 RPL5 | 5.65e-07 | 418 | 159 | 12 | 35338135 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNA FLNB FLNC MLEC MAT2A PSMA2 GPX1 ECPAS PTPN18 PGAM5 SLC1A5 RCC2 FAM120A WDR6 SDF2L1 YME1L1 FUBP3 RPL5 | 5.73e-07 | 974 | 159 | 18 | 28675297 |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 12006559 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 17360453 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 19366992 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | MAT2A RBM42 UBA3 HMGCS1 ME1 RUVBL2 PGK1 AARSD1 PM20D2 OXCT1 GLS YME1L1 FUBP3 RPL5 ATP5F1A | 9.34e-07 | 704 | 159 | 15 | 32994395 |
| Pubmed | METTL3 ERCC3 MAP4 CDK12 MAT2A PSMA2 TRPS1 ECPAS RUVBL2 PGK1 BANF1 MDN1 SBNO1 AHNAK IRF2BPL EIF3J FUBP3 SORD | 1.02e-06 | 1014 | 159 | 18 | 32416067 | |
| Pubmed | FLNA FLNC RPLP2 MYCBP2 MAP4 MAT2A MDH2 ECPAS RUVBL2 PGAM5 RCC2 MDN1 FAM120A AHNAK RPL5 ATP5F1A | 1.06e-06 | 809 | 159 | 16 | 32129710 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA FLNB FLNC RPLP2 MYCBP2 MAP4 MDH2 PLXNB2 RUVBL2 PGAM5 SLC1A5 PGK1 RCC2 MDN1 AHNAK FUBP3 RPL5 ATP5F1A | 1.17e-06 | 1024 | 159 | 18 | 24711643 |
| Pubmed | FLNA FLNB FLNC MAP4 MDH2 RUVBL2 PGAM5 PGK1 FAM120A ANGEL2 FUBP3 RPL5 ATP5F1A | 1.69e-06 | 551 | 159 | 13 | 34728620 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | FLNB RPLP2 MAT2A PSMA2 CAST MDH2 RUVBL2 PGK1 MDN1 AHNAK GMPPA YME1L1 RPL5 ATP5F1A | 1.83e-06 | 647 | 159 | 14 | 26618866 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FLNA FLNB ERCC3 RPLP2 MAP4 MAT1A MAT2A PGAM5 RCC2 NEDD9 TGM1 FAM120A SLC25A1 AHNAK RPL5 ATP5F1A ADGRA3 | 1.83e-06 | 949 | 159 | 17 | 36574265 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA FLNB RPLP2 MAP4 SCAF8 MAT2A CAST TACC2 MDH2 WNK1 RUVBL2 PGAM5 PGK1 RCC2 SBNO1 SLC25A1 AHNAK SDF2L1 EIF3J RPL5 ATP5F1A | 2.13e-06 | 1415 | 159 | 21 | 28515276 |
| Pubmed | 2.21e-06 | 46 | 159 | 5 | 33403043 | ||
| Pubmed | FLNA FLNB RPLP2 MAP4 CDK12 MAT2A SPEG PSMA2 CAST RBM42 USP37 RUVBL2 PGAM5 BANF1 RCC2 FAM120A ALDH1L2 | 2.49e-06 | 971 | 159 | 17 | 33306668 | |
| Pubmed | FLNA FLNB MLEC PSMA2 MDH2 ECPAS PGAM5 SLC1A5 BANF1 RCC2 OXCT1 MDN1 FAM120A WDR6 AHNAK SDF2L1 IRF2BPL EIF3J FUBP3 ATP5F1A CDK4 | 2.80e-06 | 1440 | 159 | 21 | 30833792 | |
| Pubmed | 2.98e-06 | 191 | 159 | 8 | 33762435 | ||
| Pubmed | FLNA FLNC MAT2A PSMA2 SQLE ECPAS SLC1A5 SLC25A1 VPS13A RPL5 ATP5F1A | 3.10e-06 | 408 | 159 | 11 | 33766124 | |
| Pubmed | 3.10e-06 | 135 | 159 | 7 | 31405213 | ||
| Pubmed | FLNA FLNB FLNC RPLP2 MAP4 MDH2 ECPAS RUVBL2 PGK1 FAM120A AHNAK RPL5 | 3.19e-06 | 494 | 159 | 12 | 26831064 | |
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 16076904 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | FLNA FLNB RPLP2 MAP4 MAT2A PSMA2 UBA3 RUVBL2 PGK1 EIF3J RPL5 ATP5F1A | 3.26e-06 | 495 | 159 | 12 | 28581483 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | FLNA FLNB GNPDA1 MAP4 CDK12 ECPAS RUVBL2 RCC2 AARSD1 SLC25A1 AHNAK RPL5 | 3.47e-06 | 498 | 159 | 12 | 36634849 |
| Pubmed | 4.22e-06 | 341 | 159 | 10 | 29791485 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNA FLNB COL6A3 GNPDA1 VPS13C PSMA2 CDHR5 RRAS MDH2 VPS13D GK2 SLC25A1 AHNAK ATP6V0D2 MBD5 ATP5F1A SORD | 4.54e-06 | 1016 | 159 | 17 | 19056867 |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 4.95e-06 | 54 | 159 | 5 | 25631074 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | AUH MYCBP2 VPS13C PSMA2 TACC2 MDH2 PLXNB2 PGAM5 USP19 VPS13D OXCT1 MDN1 FAM120A WDR6 ALDH1L2 ANGEL2 GLS VPS13A YME1L1 FUBP3 ATP5F1A | 5.05e-06 | 1496 | 159 | 21 | 32877691 |
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 5.16e-06 | 8 | 159 | 3 | 17145501 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA FLNB METTL3 ERCC3 RPLP2 MAP4 MAT2A RUVBL2 PGAM5 PGK1 RCC2 FAM120A WDR6 SLC25A1 AHNAK ANGEL2 GLS RPL5 ATP5F1A | 5.23e-06 | 1257 | 159 | 19 | 36526897 |
| Pubmed | FLNA FLNB METTL3 RPLP2 MAP4 MAT2A SQLE GPX1 ECPAS RUVBL2 RCC2 FUBP3 RPL5 ATP5F1A | 5.40e-06 | 711 | 159 | 14 | 33022573 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | AVEN FLNA FLNC ERCC3 MYCBP2 MAP4 CAST RUVBL2 FAM120A LPCAT2 WDR6 AHNAK FUBP3 RPL5 | 6.63e-06 | 724 | 159 | 14 | 36232890 |
| Pubmed | 6.79e-06 | 152 | 159 | 7 | 16009940 | ||
| Pubmed | 7.13e-06 | 215 | 159 | 8 | 35973513 | ||
| Pubmed | FLNA FLNB RPLP2 PSMA2 CAST UBA3 PGK1 AARSD1 MDN1 AHNAK MYO18B RPL5 | 7.57e-06 | 538 | 159 | 12 | 28524877 | |
| Pubmed | 7.72e-06 | 9 | 159 | 3 | 11807098 | ||
| Pubmed | FLNA FLNB MLEC RPLP2 MYCBP2 MAT2A ITGA5 MDH2 WNK1 PLXNB2 SLC1A5 PM20D2 FAM120A WDR6 AHNAK GLS SDF2L1 ATP5F1A SORD | 8.15e-06 | 1297 | 159 | 19 | 33545068 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | FLNA FLNB FLNC RPLP2 MAT2A PSMA2 MDH2 WNK1 RUVBL2 PGK1 BANF1 MDN1 LPCAT2 RPL5 ATP5F1A | 8.76e-06 | 847 | 159 | 15 | 35235311 |
| Pubmed | 9.31e-06 | 223 | 159 | 8 | 20020773 | ||
| Pubmed | 1.03e-05 | 226 | 159 | 8 | 31452512 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | FLNA FLNC RPLP2 MAT2A MDH2 RUVBL2 PGAM5 PGK1 TGM1 AHNAK RPL5 ATP5F1A | 1.09e-05 | 558 | 159 | 12 | 27591049 |
| Pubmed | FLNA RPLP2 MAP4 TRPS1 RUVBL2 PGAM5 BANF1 RCC2 TNRC18 FAM120A SLC25A1 RPL5 ATP5F1A | 1.09e-05 | 655 | 159 | 13 | 35819319 | |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | FLNA FLNB FLNC MLEC RPLP2 RUVBL2 PGAM5 SLC1A5 SLC25A1 RPL5 ATP5F1A | 1.13e-05 | 468 | 159 | 11 | 36042349 |
| Pubmed | RPLP2 MAP4 PSMA2 RUVBL2 PGAM5 SLC1A5 RCC2 FAM120A SLC25A1 FUBP3 ATP5F1A | 1.15e-05 | 469 | 159 | 11 | 37314180 | |
| Pubmed | FLNA MYCBP2 MAP4 MAT2A PSMA2 HMGCS1 ECPAS RUVBL2 AHDC1 PGK1 BANF1 RCC2 TNRC18 FAM120A FUBP3 RPL5 SORD | 1.32e-05 | 1103 | 159 | 17 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA FLNC MYCBP2 CDK12 SPEG MLLT10 ITGA5 WNK1 PLXNB2 AHDC1 SLC1A5 BANF1 TNRC18 MDN1 KCNH2 AHNAK MBD5 | 1.35e-05 | 1105 | 159 | 17 | 35748872 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.36e-05 | 235 | 159 | 8 | 30258100 | |
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 36579465 | ||
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 19015242 | ||
| Pubmed | FLNA FLNB FLNC PGAM5 RCC2 MDN1 WDR6 SLC25A1 FUBP3 RPL5 ATP5F1A | 1.54e-05 | 484 | 159 | 11 | 31995728 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.59e-05 | 315 | 159 | 9 | 26777405 | |
| Pubmed | AVEN FLNA ERCC3 AUH MAP4 CDK12 RBM42 MDH2 RUVBL2 PGAM5 SLC1A5 PGK1 FAM120A WDR6 SLC25A1 AHNAK GPATCH11 FUBP3 ATP5F1A | 1.76e-05 | 1371 | 159 | 19 | 36244648 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MLEC RPLP2 MYCBP2 MAT2A PSMA2 RUVBL2 PGAM5 SLC1A5 RCC2 MDN1 WDR6 SLC25A1 GMPPA YME1L1 FUBP3 RPL5 ATP5F1A CDK4 | 1.94e-05 | 1257 | 159 | 18 | 37317656 |
| Pubmed | A role for Saccharomyces cerevisiae Centrin (Cdc31) in mitochondrial function and biogenesis. | 2.00e-05 | 12 | 159 | 3 | 30251372 | |
| Pubmed | Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. | 2.08e-05 | 2 | 159 | 2 | 12965206 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12616532 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22318685 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 17635842 | ||
| Pubmed | R-Ras interacts with filamin a to maintain endothelial barrier function. | 2.08e-05 | 2 | 159 | 2 | 21660952 | |
| Pubmed | Functional regulation of semaphorin receptors by proprotein convertases. | 2.08e-05 | 2 | 159 | 2 | 12533544 | |
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 2.08e-05 | 2 | 159 | 2 | 9694715 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 29749642 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 7689010 | ||
| Pubmed | Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions. | 2.08e-05 | 2 | 159 | 2 | 21325628 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 10679933 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31234428 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 29448301 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 17417066 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19382234 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 2.08e-05 | 2 | 159 | 2 | 24469451 | |
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 2.08e-05 | 2 | 159 | 2 | 17196930 | |
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 2.08e-05 | 2 | 159 | 2 | 12525170 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11336782 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 33649519 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 27076759 | ||
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 2.08e-05 | 2 | 159 | 2 | 14697259 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 218932 | ||
| Interaction | BAP1 interactions | FLNA FLNB FLNC KLF8 RPLP2 MYCBP2 MAP4 CDK12 MAT2A PSMA2 CAST HMGCS1 MDH2 ECPAS ME1 RUVBL2 PGAM5 PGK1 BANF1 RCC2 TLX1 PCYOX1L MDN1 FAM120A ALDH1L2 AHNAK SDF2L1 EIF3J MBD5 RPL5 ATP5F1A | 1.81e-08 | 1314 | 155 | 31 | int:BAP1 |
| Interaction | AGR2 interactions | FLNA FLNB FLNC MLEC MYCBP2 PSMA2 PCDHA8 MUC5B MDH2 ECPAS ME1 RUVBL2 SLC1A5 PGK1 DUOX1 MDN1 SLC25A1 AHNAK RPL5 ATP5F1A SORD | 1.00e-05 | 934 | 155 | 21 | int:AGR2 |
| Interaction | B3GNT2 interactions | RPLP2 MAP4 HMGCS1 ECPAS RUVBL2 PGAM5 PGK1 RCC2 TGM1 SLC25A1 AHNAK SDF2L1 EIF3J FUBP3 RPL5 | 1.97e-05 | 542 | 155 | 15 | int:B3GNT2 |
| Interaction | PABPC1 interactions | FLNA FLNB FLNC GNPDA1 RPLP2 MAP4 MAT2A CAST RBM42 AIRE RCC2 FAM120A AHNAK PAN3 FUBP3 RPL5 ATP5F1A | 2.82e-05 | 699 | 155 | 17 | int:PABPC1 |
| Interaction | FN1 interactions | FLNA FLNB FLNC RPLP2 MAP4 PSMA2 ITGA5 MDH2 ECPAS RUVBL2 PGAM5 PGK1 RCC2 MDN1 SLC25A1 AHNAK FUBP3 RPL5 ATP5F1A | 2.88e-05 | 848 | 155 | 19 | int:FN1 |
| Interaction | SERBP1 interactions | FLNA FLNB MLEC MAP4 CDK12 MAT2A RBM42 UBA3 HMGCS1 MDH2 ECPAS RUVBL2 PGAM5 SLC1A5 RCC2 USP19 FAM120A SLC25A1 GLS MBD5 GMPPA FUBP3 RPL5 ATP5F1A CDK4 SORD | 3.52e-05 | 1432 | 155 | 26 | int:SERBP1 |
| Interaction | FBXL7 interactions | 4.41e-05 | 26 | 155 | 4 | int:FBXL7 | |
| Interaction | PSMD12 interactions | 5.25e-05 | 331 | 155 | 11 | int:PSMD12 | |
| Interaction | AR interactions | FLNA ERCC3 MYCBP2 VPS13C PSMA2 TRPS1 SHB ECPAS ME1 RUVBL2 AHDC1 PGAM5 PGK1 RCC2 TNRC18 MDN1 SHE IRF2BPL FUBP3 ATP5F1A | 7.67e-05 | 992 | 155 | 20 | int:AR |
| Interaction | G3BP1 interactions | FLNA FLNB KLF8 RPLP2 MYCBP2 MAP4 PPM1D HMGCS1 PGAM5 BANF1 RCC2 USP19 FAM120A SLC25A1 EIF3J FUBP3 RPL5 ATP5F1A | 7.78e-05 | 835 | 155 | 18 | int:G3BP1 |
| Interaction | EEF1A1 interactions | FLNA FLNB METTL3 RPLP2 CDK12 MAT1A PSMA2 RRAS ECPAS RUVBL2 PGK1 RCC2 TNRC18 AHNAK VPS13A RPL5 ATP5F1A | 8.22e-05 | 762 | 155 | 17 | int:EEF1A1 |
| Cytoband | 19q13.3 | 1.03e-05 | 82 | 159 | 5 | 19q13.3 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_UP | 3.88e-06 | 200 | 159 | 9 | M4119 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS | 7.88e-06 | 165 | 159 | 8 | M40012 | |
| Coexpression | ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP | 1.25e-05 | 84 | 159 | 6 | M2221 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP | 2.64e-05 | 195 | 159 | 8 | M3184 | |
| Coexpression | ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR | 2.68e-05 | 96 | 159 | 6 | M39211 | |
| Coexpression | LIAO_METASTASIS | FLNA GNPDA1 ASRGL1 MAP4 VPS13C TRPS1 RRAS VSIG10 RUVBL2 RCC2 SBNO1 KCNH2 GLS | 2.72e-05 | 540 | 159 | 13 | M13809 |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP | 2.95e-05 | 198 | 159 | 8 | M5011 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | FLNA MLEC RPLP2 MYCBP2 MAT2A TACC2 TNRC18 AHNAK IRF2BPL ATP6V0D2 RPL5 | 3.05e-05 | 394 | 159 | 11 | MM3724 |
| Coexpression | GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 3.05e-05 | 199 | 159 | 8 | M8380 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN | 3.05e-05 | 199 | 159 | 8 | M8314 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 5.02e-05 | 276 | 159 | 9 | M3063 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 1.11e-04 | 41 | 159 | 4 | M39158 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | FLNB MLEC CAST HMGCS1 ME1 SLC7A8 FAM120A AHNAK SDF2L1 SMPD3 EIF3J | 1.17e-04 | 458 | 159 | 11 | M40010 |
| Coexpression | TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL | RPLP2 PSMA2 GPX1 ABCC5 MDH2 SLC1A5 PGK1 ADH7 AHNAK RPL5 ATP5F1A CDK4 SORD | 1.27e-04 | 629 | 159 | 13 | M41652 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | FLNA COL6A3 IFI27L2 MAP4 SPEG ABCC5 PTPN18 PLXNB2 SLC1A5 SVEP1 GGT5 TMEM273 NEDD9 SLC7A8 OXCT1 LPCAT2 PLA2G4A SDF2L1 ATP6V0D2 SLAMF7 | 1.46e-04 | 1316 | 159 | 20 | MM1052 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | FLNA COL6A3 MAP4 SPEG ABCC5 PTPN18 PLXNB2 SLC1A5 SVEP1 GGT5 TMEM273 NEDD9 SLC7A8 OXCT1 LPCAT2 PLA2G4A SDF2L1 ATP6V0D2 SLAMF7 | 1.98e-04 | 1242 | 159 | 19 | M1920 |
| Coexpression | GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 2.01e-04 | 196 | 159 | 7 | M9515 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN | 2.01e-04 | 196 | 159 | 7 | M8757 | |
| Coexpression | GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP | 2.07e-04 | 197 | 159 | 7 | M9725 | |
| Coexpression | GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP | 2.14e-04 | 198 | 159 | 7 | M8423 | |
| Coexpression | GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN | 2.14e-04 | 198 | 159 | 7 | M9800 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP | 2.14e-04 | 198 | 159 | 7 | M8730 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP | 2.21e-04 | 199 | 159 | 7 | M3677 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP | 2.27e-04 | 200 | 159 | 7 | M9316 | |
| Coexpression | GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN | 2.27e-04 | 200 | 159 | 7 | M322 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP | 2.27e-04 | 200 | 159 | 7 | M4545 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP | 2.27e-04 | 200 | 159 | 7 | M8308 | |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP | 2.27e-04 | 200 | 159 | 7 | M8539 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP | 2.27e-04 | 200 | 159 | 7 | M3863 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP | 2.27e-04 | 200 | 159 | 7 | M3860 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN | 2.27e-04 | 200 | 159 | 7 | M6258 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_UP | 2.27e-04 | 200 | 159 | 7 | M5181 | |
| Coexpression | HALLMARK_MTORC1_SIGNALING | 2.27e-04 | 200 | 159 | 7 | M5924 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 2.27e-04 | 200 | 159 | 7 | M9002 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP | 2.27e-04 | 200 | 159 | 7 | M9080 | |
| Coexpression | GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP | 2.27e-04 | 200 | 159 | 7 | M5503 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN | 2.27e-04 | 200 | 159 | 7 | M4386 | |
| Coexpression | VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP | 2.31e-04 | 20 | 159 | 3 | M41079 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | FLNA FLNB FLNC MLEC SQLE ABCC5 ITGA5 PLXNB2 USP19 TNRC18 SMPD3 PAN3 ADGRA3 | 2.75e-04 | 681 | 159 | 13 | M5314 |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-08 | 177 | 159 | 9 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.15e-08 | 198 | 159 | 9 | cb8f099cf4ed320615b1c60ddab86b89d8db9a43 | |
| ToppCell | mild-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.15e-08 | 198 | 159 | 9 | ba97ff6e9d400b53ad013dce54afd7154a0f4fc9 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.84e-07 | 170 | 159 | 8 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-07 | 171 | 159 | 8 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | IGHV3-21 IGHV3-15 IGHV3-11 NOXRED1 IGHD ALDH1L2 SDF2L1 SLAMF7 | 2.50e-07 | 177 | 159 | 8 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | IGHV3-21 IGHV3-15 IGHV3-11 NOXRED1 IGHD ALDH1L2 SDF2L1 SLAMF7 | 2.50e-07 | 177 | 159 | 8 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-07 | 179 | 159 | 8 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-07 | 179 | 159 | 8 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.97e-07 | 181 | 159 | 8 | d909821355f4bc9e35387cda6ecf7c56793d9da4 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.97e-07 | 181 | 159 | 8 | 52935c496b45207a173b5ac7812f46210c3f74b0 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.47e-07 | 191 | 159 | 8 | 17746a32f723c078aba1f7e320b0e3f1ab8bf5c6 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.47e-07 | 191 | 159 | 8 | c2c450df810f83163987cd0f7ed9b50025cd3de1 | |
| ToppCell | facs-Lung-EPCAM|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-07 | 191 | 159 | 8 | 00957dd6077e107722835084d769e84eace0611f | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.64e-07 | 197 | 159 | 8 | 2662138671262b30508c5759038bcdcfe6551696 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 160 | 159 | 7 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.11e-06 | 164 | 159 | 7 | 92fb94492fc2b683e9d50a9db6f01d23c194b0e4 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 165 | 159 | 7 | 11227bff52eed30b80937fdb1968d0b8e6d30365 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 165 | 159 | 7 | 036f9749048e5e50769cc3210339bf4da469215d | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-06 | 177 | 159 | 7 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.49e-06 | 177 | 159 | 7 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-06 | 178 | 159 | 7 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | mild-Lymphocytic-B_cells_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.62e-06 | 178 | 159 | 7 | c6fb21401ad802a57e4e4f5a1723c42779fdb33e | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-06 | 180 | 159 | 7 | b83d067dee641941c596e4a25d81327931b6ad61 | |
| ToppCell | droplet-Limb_Muscle-nan-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-06 | 180 | 159 | 7 | d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.90e-06 | 180 | 159 | 7 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-06 | 181 | 159 | 7 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 181 | 159 | 7 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 182 | 159 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|normal_Lung / Location, Cell class and cell subclass | 4.20e-06 | 182 | 159 | 7 | 13c39228f76495deca6b948483bbde426b3e8c5b | |
| ToppCell | Control-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.84e-06 | 186 | 159 | 7 | 80f6f25dbe3c5efe4bc350f5d2eb990c38aab338 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-06 | 188 | 159 | 7 | bfd3b4f57785596b2bd2c657e0d2d8b0f40ba36d | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.57e-06 | 190 | 159 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | facs-Lung-EPCAM-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 193 | 159 | 7 | b9ac74357435f2f24aaede62b2a1d31b5d96a12c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 193 | 159 | 7 | 325859399411d0e66a78a385dffa886df9af3198 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 193 | 159 | 7 | 13282e849b11f48085f0840d112a06e896b32cd7 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 193 | 159 | 7 | 63205026e20cf2c7bfb7d08bba48d5df7976ccca | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 196 | 159 | 7 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 196 | 159 | 7 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 196 | 159 | 7 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.82e-06 | 196 | 159 | 7 | e9fe5090452ffdde4bb81b62d57037d823281d00 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.82e-06 | 196 | 159 | 7 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.82e-06 | 196 | 159 | 7 | 3cf73b33330b9fca5c8abf03f2f0d8244245b522 | |
| ToppCell | Biopsy_Other_PF-Immune-B_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.82e-06 | 196 | 159 | 7 | 123cd893fd1ae315a655e909c08528f82e9013ff | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.05e-06 | 197 | 159 | 7 | 88b29d205237f07a9a26cc15a1cf4ed4816a4c4b | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.05e-06 | 197 | 159 | 7 | 76465bb2408c7c75f694e8f7cf1a606b796afc3a | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.05e-06 | 197 | 159 | 7 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.29e-06 | 198 | 159 | 7 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.53e-06 | 199 | 159 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.53e-06 | 199 | 159 | 7 | 8e02d3a066e79e0f2024a10738e0ea070513ef19 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.53e-06 | 199 | 159 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.78e-06 | 200 | 159 | 7 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.78e-06 | 200 | 159 | 7 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.78e-06 | 200 | 159 | 7 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | mild_COVID-19-B_cell|mild_COVID-19 / disease group, cell group and cell class (v2) | 8.04e-06 | 132 | 159 | 6 | 4b372483bc106aecc7b96a09131e1695e54e7dc4 | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.54e-05 | 148 | 159 | 6 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 1.93e-05 | 154 | 159 | 6 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | facs-Heart-RA-24m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 166 | 159 | 6 | e868e90b5272da6ccfc1c371e1b1aac1d63c5139 | |
| ToppCell | facs-Heart-RA-24m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 166 | 159 | 6 | af30d3fa9380056be17b0dc720c8be09418b5529 | |
| ToppCell | facs-Heart-RA-24m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 166 | 159 | 6 | fb3daa5e5a6d9ecf52ef2e019258e84761e87b65 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.05e-05 | 167 | 159 | 6 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 168 | 159 | 6 | 624cf8f439c0a3c877927e085ec260ca79896b5a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 168 | 159 | 6 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 168 | 159 | 6 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.48e-05 | 171 | 159 | 6 | 8772d6349db24de47f089df2032a80345db7177f | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 172 | 159 | 6 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 172 | 159 | 6 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 172 | 159 | 6 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 172 | 159 | 6 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-05 | 173 | 159 | 6 | 3001dd39244ef0a5a475d569a78f4ae427a55db6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-05 | 173 | 159 | 6 | c88883fb2a33e21d4201aa393674aa3f2ad780c9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-05 | 174 | 159 | 6 | 02ab165b064acb91f2d3f59cc5be195899d61a83 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 174 | 159 | 6 | 118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0 | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 3.84e-05 | 174 | 159 | 6 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.96e-05 | 175 | 159 | 6 | fa53ea81ad943a2cd266114829135cbcbcf2f634 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 176 | 159 | 6 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 176 | 159 | 6 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 4.09e-05 | 176 | 159 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 4.09e-05 | 176 | 159 | 6 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-05 | 177 | 159 | 6 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-05 | 177 | 159 | 6 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.22e-05 | 177 | 159 | 6 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.22e-05 | 177 | 159 | 6 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.22e-05 | 177 | 159 | 6 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.22e-05 | 177 | 159 | 6 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | ASK452-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.50e-05 | 179 | 159 | 6 | c3cf49c069e66db16d2fce1de4c52a4c4fe7e832 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.50e-05 | 179 | 159 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_straight_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 180 | 159 | 6 | b34d933cdabf692f02eaaf65c2aaca1fb9510627 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.64e-05 | 180 | 159 | 6 | cd04d7bf92986a5b8a0193c9b92ec47da3929bac | |
| ToppCell | cellseq-Immune-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.64e-05 | 180 | 159 | 6 | 663a800ab70e7ab7d13183417f9c1ed36907aa5e | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.64e-05 | 180 | 159 | 6 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | Healthy-B_memory|Healthy / disease group, cell group and cell class | 4.78e-05 | 181 | 159 | 6 | 7b903076efb90026b9845af0c7a840901451193a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.93e-05 | 182 | 159 | 6 | 5f1f10c845b73d1f69794277925ef847ff23ac2d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 183 | 159 | 6 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Memory_B_cells|blood / Manually curated celltypes from each tissue | 5.08e-05 | 183 | 159 | 6 | e3a418b745d7f040adf47be9e1043b945cae47ed | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 5.24e-05 | 184 | 159 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.40e-05 | 185 | 159 | 6 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 185 | 159 | 6 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 185 | 159 | 6 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 185 | 159 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| Drug | hydroxyl radicals | COL6A3 GALC GNPDA1 ASRGL1 AUH MYCBP2 PPM1D MAT1A SQLE HMGCS1 MDH2 USP37 PTPN18 GGT5 ADH7 TGM1 PCYOX1L PLA2G4C ALDH1L2 SLC25A1 GNPDA2 GLS TGDS PLA2G4A ATP6V0D2 SMPD3 NXPH4 ATP5F1A OPLAH | 3.15e-08 | 1341 | 156 | 29 | CID000000961 |
| Drug | AC1Q68Z5 | METTL3 GNPDA1 ERCC3 AUH MAT2A HMGCS1 GMPR2 MDH2 ME1 OXCT1 LPCAT2 GNPDA2 GLS VPS13A GMPR | 7.21e-08 | 386 | 156 | 15 | CID000000181 |
| Drug | phosphoenolpyruvate | 1.96e-06 | 210 | 156 | 10 | CID000001005 | |
| Drug | monochlorobimane | 3.36e-06 | 34 | 156 | 5 | CID000114886 | |
| Drug | AC1O3LUB | 6.08e-06 | 66 | 156 | 6 | CID006331868 | |
| Drug | salsalate | 6.08e-06 | 66 | 156 | 6 | CID000005161 | |
| Drug | Zorubicin HCl | 6.22e-06 | 6 | 156 | 3 | CID000037465 | |
| Drug | 3,4,5,3',4'-pentachlorobiphenyl | FLNB ADCY4 GNPDA1 PRSS12 SQLE ABCC5 HMGCS1 ME1 SLC1A5 PGK1 BANF1 ABCC6 ADH7 SLC7A8 KCNH2 AHNAK PLA2G4A GMPR SMPD3 RPL5 NXPH4 RBBP9 OPLAH | 9.77e-06 | 1219 | 156 | 23 | ctd:C023035 |
| Drug | acivicin | 1.38e-05 | 76 | 156 | 6 | CID000002007 | |
| Drug | malonate | 1.45e-05 | 209 | 156 | 9 | CID000000867 | |
| Drug | acetate | FLNB GNPDA1 MAT2A MDH2 ME1 PGK1 ADH7 HAVCR1 OXCT1 LPCAT2 GNPDA2 DNAH9 ATP5F1A RBBP9 SORD | 1.66e-05 | 599 | 156 | 15 | CID000000175 |
| Drug | D-glucosamine-6P | 1.72e-05 | 8 | 156 | 3 | CID000121988 | |
| Drug | thiazole-4-carboxamide adenine dinucleotide | 2.40e-05 | 25 | 156 | 4 | CID000073680 | |
| Drug | thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.37e-05 | 179 | 156 | 8 | 7103_DN | |
| Drug | glutamate | ADCY4 AUH MAP4 MAT2A NRG2 MDH2 ME1 SLC1A5 PGK1 GGT5 SLC7A8 OXCT1 MDN1 GLS LRCH4 SLC17A8 YME1L1 OPLAH SORD | 3.37e-05 | 962 | 156 | 19 | CID000000611 |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.50e-05 | 180 | 156 | 8 | 3290_DN | |
| Drug | 2-butenedioate | 3.53e-05 | 234 | 156 | 9 | CID000000723 | |
| Drug | AC1ODU4J | 3.66e-05 | 10 | 156 | 3 | CID000151277 | |
| Drug | verbenone | 3.66e-05 | 10 | 156 | 3 | CID000029025 | |
| Drug | 4HADNT | 3.66e-05 | 10 | 156 | 3 | CID005375469 | |
| Drug | 3-nitrofluoranthen-6-ol | 4.66e-05 | 2 | 156 | 2 | CID000146572 | |
| Drug | 3-nitrofluoranthen-9-ol | 4.66e-05 | 2 | 156 | 2 | CID000146573 | |
| Drug | 3-nitrofluoranthen-8-ol | 4.66e-05 | 2 | 156 | 2 | CID000146567 | |
| Drug | 1,3,6-trinitropyrene | 4.66e-05 | 2 | 156 | 2 | CID000053229 | |
| Drug | AC1L25J4 | 4.66e-05 | 2 | 156 | 2 | CID000041328 | |
| Drug | 2-methylcarbazole | 4.66e-05 | 2 | 156 | 2 | CID000019290 | |
| Drug | m-nitrobenzamidine hydrochloride | 4.66e-05 | 2 | 156 | 2 | CID000165122 | |
| Drug | 2-nitrobenzofuran | 4.66e-05 | 2 | 156 | 2 | CID000036328 | |
| Drug | 1,3,6,8-tetranitropyrene | 4.66e-05 | 2 | 156 | 2 | CID000034321 | |
| Drug | 2-amino-4-methylthio-3-butenoic acid | 4.66e-05 | 2 | 156 | 2 | ctd:C083253 | |
| Drug | AC1L1IZ2 | ADCY4 MAT1A MAT2A MDH2 WNK1 PGK1 MYO18B DNAH9 YME1L1 ATP5F1A | 4.89e-05 | 304 | 156 | 10 | CID000004795 |
| Drug | ammonia | GNPDA1 ASRGL1 MAT1A MAT2A GMPR2 MDH2 ME1 BANF1 TGM1 GNPDA2 GLS GMPR SLAMF7 | 5.09e-05 | 509 | 156 | 13 | CID000000222 |
| Drug | Vancomycin | FLNA COL6A3 AUH PRSS12 SQLE TACC2 RRAS WNK1 PTPN18 RCC2 SLC7A8 HAVCR1 TGM1 OXCT1 AHNAK DTX4 PLA2G4A SORD | 5.10e-05 | 906 | 156 | 18 | ctd:D014640 |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.17e-05 | 195 | 156 | 8 | 4180_DN | |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 4532_DN | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 3388_UP | |
| Drug | AC1L1I1P | 6.69e-05 | 62 | 156 | 5 | CID000004385 | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 6136_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | 7.11e-05 | 199 | 156 | 8 | 122_DN | |
| Drug | Zearalenone | ERCC3 ASRGL1 SQLE GPX1 ABCC5 MUC5B HMGCS1 MDH2 SLC1A5 PGK1 ADH7 | 8.02e-05 | 389 | 156 | 11 | ctd:D015025 |
| Drug | dioscin | 8.58e-05 | 13 | 156 | 3 | CID000119245 | |
| Drug | alanine | 1.03e-04 | 269 | 156 | 9 | CID000000602 | |
| Drug | ronidazole | 1.09e-04 | 14 | 156 | 3 | CID000005094 | |
| Drug | ANIT | 1.12e-04 | 69 | 156 | 5 | CID000011080 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.39e-07 | 3 | 154 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.39e-07 | 3 | 154 | 3 | DOID:0111611 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.39e-07 | 3 | 154 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.27e-04 | 19 | 154 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Medullary Neoplasms | 1.61e-04 | 4 | 154 | 2 | C0751887 | |
| Disease | Brain Stem Neoplasms, Primary | 1.61e-04 | 4 | 154 | 2 | C0751886 | |
| Disease | Pontine Tumors | 1.61e-04 | 4 | 154 | 2 | C0751889 | |
| Disease | Mesencephalic Neoplasms | 1.61e-04 | 4 | 154 | 2 | C0751888 | |
| Disease | Brain Stem Neoplasms | 1.61e-04 | 4 | 154 | 2 | C0677866 | |
| Disease | chronic obstructive pulmonary disease, CC16 measurement | 4.00e-04 | 6 | 154 | 2 | EFO_0000341, EFO_0005080 | |
| Disease | reticulocyte measurement | FLNA FLNB AUH TRPS1 EML6 GPX1 USP37 ECPAS PLXNB2 AHNAK GLS VPS13A GMPR ADGRD2 SLC7A10 | 4.25e-04 | 1053 | 154 | 15 | EFO_0010700 |
| Disease | Malignant neoplasm of breast | FLNA FLNB ERCC3 COL19A1 RPLP2 PPM1D GPX1 TACC2 ITGA9 WNK1 SBNO1 PLA2G4A DNAH9 PLXNB1 PDZD4 | 5.22e-04 | 1074 | 154 | 15 | C0006142 |
| Disease | level of oxylipin in blood plasma | 5.59e-04 | 7 | 154 | 2 | OBA_2050338 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 7.42e-04 | 8 | 154 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | atrial fibrillation | 7.69e-04 | 371 | 154 | 8 | EFO_0000275 | |
| Disease | pseudoxanthoma elasticum (is_implicated_in) | 9.51e-04 | 9 | 154 | 2 | DOID:2738 (is_implicated_in) | |
| Disease | uveitis | 9.51e-04 | 9 | 154 | 2 | EFO_1001231 | |
| Disease | Paroxysmal atrial fibrillation | 1.39e-03 | 156 | 154 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.39e-03 | 156 | 154 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.39e-03 | 156 | 154 | 5 | C2585653 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.43e-03 | 157 | 154 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Atrial Fibrillation | 1.56e-03 | 160 | 154 | 5 | C0004238 | |
| Disease | myopathy (implicated_via_orthology) | 2.03e-03 | 48 | 154 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.03e-03 | 13 | 154 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0010617 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.70e-03 | 53 | 154 | 3 | C1961099 | |
| Disease | hepcidin:transferrin saturation ratio | 2.72e-03 | 15 | 154 | 2 | EFO_0007902 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.72e-03 | 15 | 154 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | iritis | 3.50e-03 | 17 | 154 | 2 | EFO_1000997 | |
| Disease | myeloid white cell count | FLNB GNPDA1 EML6 ABCC5 CHGA GGT5 HAVCR1 SLC25A1 ADGRD2 ATP6V0D2 RMC1 PLXNB1 | 3.83e-03 | 937 | 154 | 12 | EFO_0007988 |
| Disease | Post-Traumatic Osteoporosis | 4.02e-03 | 61 | 154 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 4.02e-03 | 61 | 154 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 4.02e-03 | 61 | 154 | 3 | C0001787 | |
| Disease | serum albumin measurement | 4.02e-03 | 592 | 154 | 9 | EFO_0004535 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 4.37e-03 | 19 | 154 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Osteoporosis | 4.40e-03 | 63 | 154 | 3 | C0029456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVQKRGAPAGAGSGT | 356 | Q99952 | |
| VKPGSTCVVFGLGGV | 201 | P40394 | |
| VGAAGIPAGGVLTLA | 426 | Q15758 | |
| KAEAAEGRAPGGGLI | 211 | Q8N7J2 | |
| PGKVESGAGDAIGLA | 1091 | Q9NYV4 | |
| SIGGTSGPHVGKKVI | 141 | Q14511 | |
| GNIIGSGIFISPKGV | 51 | Q9NS82 | |
| VVHGGGAGPISKDRK | 6 | Q7L266 | |
| GGGIPIIVCGITAAA | 881 | Q8IWK6 | |
| KGVINIIPGSGGIAG | 641 | Q3SY69 | |
| GGEPVSLGSLRGKVL | 26 | P07203 | |
| GPRVAEVLEGKGAGK | 366 | Q9BTE6 | |
| GGDGVKVPGIDATTK | 5341 | Q09666 | |
| IKGGADVSGGVSAPD | 5566 | Q09666 | |
| AGGVPGRVHITGATL | 401 | Q8NFM4 | |
| AVAAAGVGGPGLTEL | 706 | Q5TGY3 | |
| AGHPGAEVALVGGLK | 491 | Q5VTE6 | |
| GTVARGAGAGVVVKD | 361 | Q9HBB8 | |
| TLGHKVLVCGAGPIG | 171 | Q00796 | |
| AGPRAGGSVVLGQVD | 36 | Q9Y2E6 | |
| VFGGIGDPVTCLKSG | 21 | O15263 | |
| VDALGNAIDGKGPIG | 151 | P25705 | |
| SGDVPGARGAVEGIL | 196 | O43918 | |
| TGGVGAVALLIGPNA | 171 | Q01581 | |
| LGGALGVPGAKESRA | 216 | O95158 | |
| LQEGTFKAVARGPGG | 966 | Q9HC84 | |
| RPATAGKAGGAAVVI | 71 | Q9P258 | |
| VAVGAGGAPAGPAVI | 266 | Q9BTD8 | |
| VGLPAKSGVAGGILL | 476 | O94925 | |
| AVVVGKGRGAPGDDS | 16 | Q86XR2 | |
| LAPRVGGTGGAVSEL | 566 | Q9UN73 | |
| GNIIGSGIFVSPKGV | 51 | Q9UHI5 | |
| PGLRAVVGGAAAVST | 436 | O75427 | |
| VGGGIGVTPFASILK | 1386 | Q9NRD9 | |
| KAVIVPGNGGGDVTT | 6 | O75884 | |
| GEKVAGLQGLGSPAL | 131 | Q8WTU0 | |
| PLTDGVIRLAGGKGS | 381 | P56730 | |
| LEPRVGGTGGAASKL | 566 | Q9Y5H6 | |
| GGTGGAASKLVPRSV | 571 | Q9Y5H6 | |
| LEGSPGVGKTSLVGA | 1751 | Q9NU22 | |
| GGGKAAVVLLAVGGQ | 281 | Q9BZJ8 | |
| VQLVESGGGLVKPGG | 21 | P01762 | |
| GGALAVGAVPVVLSA | 11 | Q9H2X8 | |
| IKPTALIGVAAIGGA | 371 | P48163 | |
| NVGHLPAGGAVKTEG | 1076 | P27816 | |
| KAAGGIELFVGGIGP | 126 | P46926 | |
| VQLVESGGGLVKPGG | 21 | A0A0B4J1V0 | |
| GLVETKLAIIPGGGG | 206 | Q13825 | |
| VEDPVRKVGGGGTAG | 21 | O75822 | |
| IRGPGLGVAGVAGAA | 26 | Q14165 | |
| VDQLKGRGGPFVDGV | 491 | O75335 | |
| KVAVLGASGGIGQPL | 26 | P40926 | |
| VIGGPQGDAGLTGRK | 251 | P31153 | |
| NPKDVLGRGAGGTFV | 521 | Q76MJ5 | |
| GGAGAPGAVVVDVDL | 186 | Q12809 | |
| TVVFQGGALGKTPDG | 1046 | Q5VYK3 | |
| GGLGLTVEGPCEAKI | 1071 | O75369 | |
| VVASGPGLEHGKVGE | 1136 | O75369 | |
| AGAGGLSIAVEGPSK | 2221 | O75369 | |
| AEVGVGAGGKRPGSV | 321 | Q9H1B7 | |
| PGKIAVVGAGIGGSA | 26 | Q8NBM8 | |
| AVGPGAGEAQGVPVK | 1756 | O43157 | |
| GGVEVDVFGKLGRSP | 871 | O15031 | |
| VLFSAVAVGKPRAGG | 21 | Q96HS1 | |
| LSLAGGPRVGGVAAA | 601 | Q76G19 | |
| VEGKVQGLVPAGGSS | 131 | O14511 | |
| KAEGPGLNRTGVEVG | 871 | Q14315 | |
| IDEKVGGTNLGAPGA | 421 | Q96I24 | |
| ITVPLIGGDGKNAGS | 201 | O95600 | |
| VIGGPQGDAGVTGRK | 251 | Q00266 | |
| SGADIIKVGIGPGSV | 171 | Q9P2T1 | |
| PSQGGKLEIAGTVVG | 941 | Q9NZB2 | |
| GGASLELLEGKVLPG | 396 | P00558 | |
| GEVSGKGPAVAAREA | 61 | O15297 | |
| QGGDGVARAVPGSIK | 191 | Q9NY59 | |
| IVPNSTAGLIIGKGG | 136 | Q9UNW9 | |
| AQGIGKLASVPAGGA | 56 | P05387 | |
| VQLVESGGGLVKPGG | 21 | A0A0B4J1V1 | |
| AEKKGPGEVAGTVTG | 161 | Q86U44 | |
| GSPAGGLGALLDVTK | 141 | Q8TAX0 | |
| AATVPGAGVGNVGLR | 11 | Q7L5N7 | |
| PGNTGKLFVGVGISR | 506 | Q9NQV7 | |
| LAAAVAVVAPPGVGG | 21 | Q58A45 | |
| TIDVVGGAPQDKGIG | 261 | Q13797 | |
| AEFTKTGRVVLGGPG | 211 | P08648 | |
| TPGGKIVGTLCAIAG | 431 | Q16322 | |
| AAVGSLLAGGPVVAI | 291 | O15440 | |
| APVVAVLGSGGGLRA | 41 | Q9UP65 | |
| LGPNVSIGKGVTVGE | 301 | Q96IJ6 | |
| LKGSLGTGAEEGAPV | 236 | Q14549 | |
| LGGSGPCFVLEVAKG | 21 | A4D2P6 | |
| GQALGKSGGGIVEPI | 111 | Q8N954 | |
| VDVRVKPVGAAGGSS | 126 | A4D1S0 | |
| GLIKTGALEGVPISG | 241 | Q14410 | |
| GGRGPIFELKSVAAG | 236 | Q9NQS1 | |
| FVALKSVRVPNGGGG | 31 | P11802 | |
| KGDRGEPGVIGSQGV | 491 | Q14993 | |
| AGAGGLAIAVEGPSK | 2266 | P21333 | |
| KRGGAVPIGIGIGNA | 1156 | P12111 | |
| PGVGGKRDVVFLIDG | 1226 | P12111 | |
| KLGGECVAGPVGLLS | 496 | Q14534 | |
| VAGKVPTGGVEEGLL | 206 | P01880 | |
| GEKRGGAEGSPKLAV | 6 | Q3MJ40 | |
| QGSKLVIGGAGGELI | 481 | P36269 | |
| GESVAGITAISGKPG | 111 | P20810 | |
| KEAGGIDLFVGGIGP | 126 | Q8TDQ7 | |
| VKDGLVVGGPGDASV | 1071 | Q9P267 | |
| VTGGKERPTKEGGAV | 1611 | Q6ZMW3 | |
| GLEVGPESGLAGAKA | 86 | Q9NYC9 | |
| GVIVLPCGAGKSLVG | 336 | P19447 | |
| SGADIIKVGVGPGSV | 171 | P36959 | |
| GEKPVGSLAGIGEVL | 16 | O75531 | |
| EALTKAEGRGGLPAG | 171 | Q8IVE0 | |
| PDTGGVFIAGRVNKG | 571 | P54803 | |
| TVKDVGFGSLVIPGG | 726 | Q9UPN6 | |
| SGAGGGVAAAAVPLI | 191 | Q9BXA9 | |
| DGAGVGKGRTIAGII | 321 | A3KN83 | |
| GTVKRPVLEGQGGFE | 216 | Q5FWE3 | |
| DVPVVAILGSGGGFR | 186 | P47712 | |
| SATPEEFKVGIIGGG | 71 | Q6NXP6 | |
| GKIAGRAVLIAGQPG | 66 | Q9Y230 | |
| IKVESAAGGGAGDPL | 186 | Q15464 | |
| GCLLAVVGPVGAGKS | 656 | O95255 | |
| VLHRGEAGTGTPVKG | 141 | O14841 | |
| KPLAERAGGIGGATI | 56 | Q9H6K5 | |
| DSVAGSVKVGGEAGP | 16 | Q96D42 | |
| GALKGAVDGGLSIPH | 161 | P46777 | |
| VPDGSVAAAGLGLGL | 41 | O75592 | |
| MVAGVVSVGLGGPVD | 111 | Q6ZT89 | |
| KDIPDGATVLVGGFG | 51 | P55809 | |
| ALVAGPEGKGSEAGT | 151 | Q01892 | |
| KLSDGGAGLSVGLPI | 1531 | Q4LDE5 | |
| VVVLGTPAEEDGGGK | 156 | Q8IYS1 | |
| VAPVAAGEVVKTAGG | 41 | Q7Z7M1 | |
| AVSAVGGIIGALPGN | 891 | P55197 | |
| VVPQGLFRGGKSGEL | 311 | P10645 | |
| HGEVQVLGGPDGTKV | 566 | Q9NQW8 | |
| GLPGGFAKRVLVTGG | 11 | O95455 | |
| GGAGDVGLPALVAEA | 286 | O15417 | |
| VGLPALVAEAGRGGA | 291 | O15417 | |
| GGTEGFKGNARVILP | 201 | Q8TBC4 | |
| AVETKGFLQGAPAGG | 846 | Q9UHF7 | |
| GGLEAPAARVGGAKV | 381 | O94966 | |
| LKALVGGAVGGLAGA | 2906 | Q96RL7 | |
| RAKVGAGGGAPVAVA | 26 | Q15772 | |
| LLVPGGGAAKTGAEL | 21 | Q9HCN8 | |
| GGATGVVVKGPDDRN | 41 | Q96DM3 | |
| GKAILAGGLAGGIEI | 26 | P53007 | |
| LAAVAGGAPSVGIKA | 26 | P25787 | |
| GGAPSVGIKAANGVV | 31 | P25787 | |
| GKGLVGAVARPTGGI | 3556 | Q709C8 | |
| LGALATPGEKAGAGR | 1421 | O95359 | |
| AASGPVKELVGSVGG | 21 | Q9NQ25 | |
| GGKARAGAGAPVVGS | 531 | Q9NNW5 | |
| GAKSPLEIEGAAGGL | 2306 | Q8IUG5 | |
| PGTGKTLLARAVAGE | 381 | Q96TA2 | |
| GGAGALSAAGVIRVP | 121 | P31314 | |
| PGRGSIKTVAGSGIA | 166 | Q86T82 | |
| EPGGVIVGKSKLGVE | 261 | Q8N0Z9 | |
| GKGTHVIIPVGKGGS | 176 | P22735 | |
| FITGPTGSVKIGDLG | 356 | Q9H4A3 | |
| PSETHKLVVVGGGGV | 26 | P10301 | |
| AAELGSGRAGVGPKD | 86 | Q5VZ18 | |
| VGGAQVLATGKTPGA | 16 | Q5T292 | |
| PGKEGVKNAVGDSLG | 16 | Q8NDX2 | |
| PLFEAVGGSGGKTLE | 276 | Q8N8Y2 | |
| GKGLVGTVTKPVAGA | 4186 | Q5THJ4 |